ENGLISH IVY: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews

Overview

English ivy (Hedera helix) is an evergreen, climbing vine native to Europe and Asia. The leaves are sometimes used to make extracts for medicine.

English ivy might help thin mucus in the airways. This might improve lung function in people with breathing difficulty. English ivy might also have antioxidant effects.

People use English ivy for bronchitis, burns, rheumatoid arthritis (RA), and many other purposes, but there is no good scientific evidence to support these uses.

Uses & Effectiveness

We currently have no information for ENGLISH IVY overview.

Side Effects

When taken by mouth: Specific cough syrups (Prospan; Prospanex) containing English ivy leaf extract are possibly safe when used three times daily for up to 7 days.

When applied to the skin: There isn't enough reliable information to know if English ivy is safe. It might cause side effects such as allergic skin reactions.

Special Precautions and Warnings

Pregnancy and breast-feeding: There isn't enough reliable information to know if English ivy is safe to use when pregnant or breast-feeding. Stay on the safe side and avoid use.

Children: Specific cough syrups (Prospan; Prospanex) containing English ivy leaf extract are possibly safe when taken by mouth three times daily for up to 7 days.

Interactions

Moderate Interaction

Be cautious with this combination

Medications changed by the liver (Cytochrome P450 2C19 (CYP2C19) substrates) interacts with ENGLISH IVY
Some medications are changed and broken down by the liver. English ivy might change how quickly the liver breaks down these medications. This could change the effects and side effects of these medications.
Medications changed by the liver (Cytochrome P450 2C8 (CYP2C8) substrates) interacts with ENGLISH IVY
Some medications are changed and broken down by the liver. English ivy might change how quickly the liver breaks down these medications. This could change the effects and side effects of these medications.
Medications changed by the liver (Cytochrome P450 2D6 (CYP2D6) substrates) interacts with ENGLISH IVY
Some medications are changed and broken down by the liver. English ivy might change how quickly the liver breaks down these medications. This could change the effects and side effects of these medications.

Dosing

Dried English ivy leaf has most often been used by adults in doses of 300-800 mg by mouth daily. Specific English ivy leaf extract products have also been used. Speak with a healthcare provider to find out what type of product and dose might be best for a specific condition.

View References

REFERENCES:

Abe, Y., Umemura, S., Sugimoto, K., Hirawa, N., Kato, Y., Yokoyama, N., Yokoyama, T., Iwai, J., and Ishii, M. Effect of green tea rich in gamma-aminobutyric acid on blood pressure of Dahl salt-sensitive rats. Am.J.Hypertens. 1995;8(1):74-79. View abstract.

Akama, K., Kanetou, J., Shimosaki, S., Kawakami, K., Tsuchikura, S., and Takaiwa, F. Seed-specific expression of truncated OsGAD2 produces GABA-enriched rice grains that influence a decrease in blood pressure in spontaneously hypertensive rats. Transgenic Res. 2009;18(6):865-876. View abstract.

Baldrighi, G. and Tronconi, L. [Research on the antihypertensive effect induced by the mebutamate-GABA (gamma-aminobutyric acid) combination in essential hypertension]. Clin.Ter. 5-15-1966;37(3):207-234. View abstract.

Belloni, L. and Savioli, F. [Experience in hypotensive treatment with the association of mebutamate and gamma-aminobutyric acid]. Minerva Med. 2-17-1967;58(14):501-509. View abstract.

Belloni, L., Savioli, F., and Barbieri, C. [On the antihypertensive properties of gamma-aminobutyric acid. Clinical experience in 29 hypertensive patients]. Arch.Maragliano.Patol.Clin. 1966;22(1):119-145. View abstract.

Benassi, E., Besio, G., Cupello, A., Mainardi, P., Patrone, A., Rapallino, M. V., Vignolo, L., and Loeb, C. W. Evaluation of the mechanisms by which gamma-amino-butyric acid in association with phosphatidylserine exerts an antiepileptic effect in the rat. Neurochem.Res. 1992;17(12):1229-1233. View abstract.

Cavagnini, F., Benetti, G., Invitti, C., Ramella, G., Pinto, M., Lazza, M., Dubini, A., Marelli, A., and Muller, E. E. Effect of gamma-aminobutyric acid on growth hormone and prolactin secretion in man: influence of pimozide and domperidone. J.Clin.Endocrinol.Metab 1980;51(4):789-792. View abstract.

Cho, Y. R., Chang, J. Y., and Chang, H. C. Production of gamma-aminobutyric acid (GABA) by Lactobacillus buchneri isolated from kimchi and its neuroprotective effect on neuronal cells. J.Microbiol.Biotechnol. 2007;17(1):104-109. View abstract.

Danilova, I. N., Neretin, V. I., and Nesterova, L. A. [Effect of aminalon electrophoresis on brain bioelectrical activity in cerebral atherosclerosis patients with disordered cerebral blood circulation]. Vopr.Kurortol.Fizioter.Lech.Fiz Kult. 1980;(4):13-17. View abstract.

ELLIOTT, K. A. and JASPER, H. H. Gammaaminobutyric acid. Physiol Rev. 1959;39(2):383-406. View abstract.

Enna, S. J. GABA. San Diego: Academic Press/Elsevier;2006.

Furukawa, T. and Kushiku, K. Antagonism by gamma-aminobutyric acid of the stimulant effect of angiotensin II on cardiac sympathetic ganglia in spinal dogs. Naunyn Schmiedebergs Arch.Pharmacol. 1981;317(2):149-153. View abstract.

Garkusha, L. G., Kukhtevich, I. I., and Proskurkina, O. A. [Treatment of chronic diffuse arachnoiditis with aminalon]. Vrach.Delo 1978;(1):114-116. View abstract.

Glebova, O. S. [Peculiarities of neuro-psychological and autonomic disorders in patients with remote consequences of closed craniocerebral injury]. Lik.Sprava. 2007;(5-6):85-89. View abstract.

Hayakawa, K., Kimura, M., Kasaha, K., Matsumoto, K., Sansawa, H., and Yamori, Y. Effect of a gamma-aminobutyric acid-enriched dairy product on the blood pressure of spontaneously hypertensive and normotensive Wistar-Kyoto rats. Br.J.Nutr. 2004;92(3):411-417. View abstract.

Jones, E. A., Schafer, D. F., Ferenci, P., and Pappas, S. C. The GABA hypothesis of the pathogenesis of hepatic encephalopathy: current status. Yale J.Biol.Med. 1984;57(3):301-316. View abstract.

Kawabata, K., Tanaka, T., Murakami, T., Okada, T., Murai, H., Yamamoto, T., Hara, A., Shimizu, M., Yamada, Y., Matsunaga, K., Kuno, T., Yoshimi, N., Sugie, S., and Mori, H. Dietary prevention of azoxymethane-induced colon carcinogenesis with rice-germ in F344 rats. Carcinogenesis 1999;20(11):2109-2115. View abstract.

Kemmerich, B., Eberhardt, R., and Stammer, H. Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled clinical trial. Arzneimittelforschung. 2006;56(9):652-660. View abstract.

Marzian, O. [Treatment of acute bronchitis in children and adolescents. Non-interventional postmarketing surveillance study confirms the benefit and safety of a syrup made of extracts from thyme and ivy leaves]. MMW.Fortschr.Med 6-28-2007;149(27-28 Suppl):69-74. View abstract.

Alkattan A, Alameer R, Alsalameen E, et al. Safety of English ivy (Hedera helix) leaf extract during pregnancy: retrospective cohort study. Daru 2021;29(2):493-499. View abstract.

Amara-Mokrane YA, Lehucher-Michel MP, Balansard G, et al. Protective effects of alpha-hederin, chlorophyllin and ascorbic acid towards the induction of micronuclei by doxorubicin in cultured human lymphocytes. Mutagenesis 1996;11:161-7. View abstract.

Boyle J, Harman RM. Contact dermatitis to Hedera helix (common ivy). Contact Dermatitis 1985;12(2):111-112. View abstract.

Bregnbak D, Menné T, Johansen JD. Airborne contact dermatitis caused by common ivy (Hedera helix L. ssp. helix). Contact Dermatitis. 2015;72(4):243-4. View abstract.

Fazio S, Pouso J, Dolinsky D, et al. Tolerance, safety and efficacy of Hedera helix extract in inflammatory bronchial diseases under clinical practice conditions: a prospective, open, multicentre postmarketing study in 9657 patients. Phytomedicine 2009;16(1):17-24. View abstract.

Gaillard Y, Blaise P, Darre A, Barbier T, Pepin G. An unusual case of death: suffocation caused by leaves of common ivy (Hedera helix). Detection of hederacoside C, alpha-hederin, and hederagenin by LC-EI/MS-MS. J Anal Toxicol 2003;27(4):257-262. View abstract.

García M, Fernández E, Navarro JA, et al. Allergic contact dermatitis from Hedera helix L. Contact Dermatitis 1995;33(2):133-4. View abstract.

Gulcin I, Mshvildadze V, Gepdiremen A, Elias R. Antioxidant activity of saponins isolated from ivy: alpha-hederin, hederasaponin-C, hederacolchiside-E and hederacolchiside-F. Planta Med 2004;70(6):561-563. View abstract.

Gulyas A, Repges R, Dethlefsen U. Therapy of chronic obstructive pulmonary diseases in children (Translation). Atemvegs und Lungenkrankheiten 1997;23:291-4.

Hausen BM, Brohan J, Konig WA, et al. Allergic and irritant contact dermatitis from falcarinol and didehydrofalcarinol in common ivy (Hedera helix L.). Contact Dermatitis 1987;17(1):1-9. View abstract.

Hocaoglu AB, Karaman O, Erge DO, et al. Effect of Hedera helix on lung histopathology in chronic asthma. Iran J Allergy Asthma Immunol. 2012;11(4):316-23. View abstract.

Jones JM, White IR, White JM, McFadden JP. Allergic contact dermatitis to English ivy (Hedera helix)--a case series. Contact Dermatitis. 2009 Mar;60(3):179-80. View abstract.

Kardos P, Bittner CB, Seibel J, Abramov-Sommariva D, Birring SS. Effectiveness and tolerability of the thyme/ivy herbal fluid extract BNO 1200 for the treatment of acute cough: an observational pharmacy-based study. Curr Med Res Opin 2021;37(10):1837-1844. View abstract.

Kruttschnitt E, Wegener T, Zahner C, Henzen-Bücking S. Assessment of the Efficacy and Safety of Ivy Leaf (Hedera helix) Cough Syrup Compared with Acetylcysteine in Adults and Children with Acute Bronchitis. Evid Based Complement Alternat Med. 2020 May 4;2020:1910656. View abstract.

Lurquin E, Swinnen I, Goossens A. Allergic contact dermatitis caused by Hedera helix arborescens and not by Hedera helix L. Contact Dermatitis. 2012;66(6):352-3. View abstract.

Mitchell, J. C. Allergic contact dermatitis from Hedera helix and Brassaia actinophylla (Araliaceae). Contact Dermatitis 1981;7(3):158-159. View abstract.

Paulsen E, Christensen LP, Andersen KE. Dermatitis from common ivy (Hedera helix L. subsp. helix) in Europe: past, present, and future. Contact Dermatitis. 2010;62(4):201-9. View abstract.

Rehman SU, Kim IS, Choi MS, Kim SH, Zhang Y, Yoo HH. Time-dependent Inhibition of CYP2C8 and CYP2C19 by Hedera helix Extracts, A Traditional Respiratory Herbal Medicine. Molecules. 2017;22(7). View abstract.

Saeed Khan S, Adil A, Naeem S, et al. Evaluation of Acute and Chronic Antidiabetic Activity of Ivy (Hedera helix L.) Aqueous Leaf Extract in Rat Model. Pak J Biol Sci. 2020 Jan;23(11):1357-1368. View abstract.

Shokry AA, El-Shiekh RA, Kamel G, Bakr AF, Sabry D, Ramadan A. Anti-arthritic activity of the flavonoids fraction of ivy leaves (Hedera helix L.) standardized extract in adjuvant induced arthritis model in rats in relation to its metabolite profile using LC/MS. Biomed Pharmacother 2022;145:112456. View abstract.

Yesudian PD, Franks A. Contact dermatitis from Hedera helix in a husband and wife. Contact Dermatitis 2002;46(2):125-126. View abstract.

COPD: What You Need to Know

Exercise With Pulmonary Arterial Hypertension

EGFR Exon 20 Insertion Mutation

Asthma in People of Color: Understand the Disparities

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2024 by Therapeutic Research Center, LLC. All Rights Reserved.

ENGLISH IVY - Uses, Side Effects, and More

Overview

Uses & Effectiveness

Side Effects

Special Precautions and Warnings

Interactions

Moderate Interaction

Medications changed by the liver (Cytochrome P450 2C19 (CYP2C19) substrates) interacts with ENGLISH IVY

Medications changed by the liver (Cytochrome P450 2C8 (CYP2C8) substrates) interacts with ENGLISH IVY

Medications changed by the liver (Cytochrome P450 2D6 (CYP2D6) substrates) interacts with ENGLISH IVY

Dosing

You Might Also Like